Androgen-sensitive human prostate cancer cells, LNCaP, produce both N-terminally mature and truncated prostate-specific antigen isoforms

被引:23
作者
Herrala, A
Kurkela, R
Vihinen, M
Kalkkinen, N
Vihko, P
机构
[1] Oulu Univ, Bioctr, FIN-90220 Oulu, Finland
[2] Oulu Univ, WHO, Collaborating Ctr Res Reprod Hlth, FIN-90220 Oulu, Finland
[3] Univ Helsinki, Dept Biosci, Div Biochem, FIN-00014 Helsinki, Finland
[4] Tampere Univ, Inst Med Technol, FIN-33101 Tampere, Finland
[5] Univ Helsinki, Inst Biotechnol, Prot Chem Lab, FIN-00014 Helsinki, Finland
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1998年 / 255卷 / 02期
关键词
prostate cancer; N-terminal sequencing; molecular modeling; standardization; enzyme activity;
D O I
10.1046/j.1432-1327.1998.2550329.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To characterize prostate-specific antigen (PSA) produced by cancer cells, different isoforms of PSA secreted by the human prostate cancer cells, LNCaP, were purified. LNCaP-PSA production was induced by synthetic androgen, R1881. LNCaP-PSA was separated into four pools. The molecular mass of LNCaP-PSA isoforms in these pools was 34 kDa under reducing conditions and 29 kDa under nonreducing conditions on SDS/PAGE. pI of LNCaP-PSA isoforms varied from 6.8 to 8.2. Pool A had the highest specific activity, 37 nmol/(minxmg). All the pools formed stable complexes with alpha 1-antichymotrypsin and alpha 2-macroglobulin. The Fools contained 10-60% of N-terminally correctly processed LNCaP-PSA isoforms. According to the molecular modelling, the addition or deletion of two or four N-terminal amino acids could affect the three-dimensional structure and thereby remarkably reduce the enzyme activity of LNCaP-PSA.
引用
收藏
页码:329 / 335
页数:7
相关论文
共 58 条
[1]   THE CHYMOTRYPSIN-LIKE ACTIVITY OF HUMAN PROSTATE-SPECIFIC ANTIGEN, GAMMA-SEMINOPROTEIN [J].
AKIYAMA, K ;
NAKAMURA, T ;
IWANAGA, S ;
HARA, M .
FEBS LETTERS, 1987, 225 (1-2) :168-172
[2]  
ANDREWS AT, 1981, ELECTROPHORESIS THEO, P63
[3]  
BABAIAN RJ, 1991, CANCER-AM CANCER SOC, V67, P2200, DOI 10.1002/1097-0142(19910415)67:8<2200::AID-CNCR2820670833>3.0.CO
[4]  
2-E
[5]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[6]   ALPHA(1)-ANTICHYMOTRYPSIN PRODUCTION IN PSA-PRODUCING CELLS IS COMMON IN PROSTATE-CANCER BUT RARE IN BENIGN PROSTATIC HYPERPLASIA [J].
BJORK, T ;
BJARTELL, A ;
ABRAHAMSSON, PA ;
HULKKO, S ;
DISANTAGNESE, A ;
LILJA, H .
UROLOGY, 1994, 43 (04) :427-434
[7]   REFINED 2 A X-RAY CRYSTAL-STRUCTURE OF PORCINE PANCREATIC KALLIKREIN-A, A SPECIFIC TRYPSIN-LIKE SERINE PROTEINASE - CRYSTALLIZATION, STRUCTURE DETERMINATION, CRYSTALLOGRAPHIC REFINEMENT, STRUCTURE AND ITS COMPARISON WITH BOVINE TRYPSIN [J].
BODE, W ;
CHEN, ZG ;
BARTELS, K ;
KUTZBACH, C ;
SCHMIDTKASTNER, G ;
BARTUNIK, H .
JOURNAL OF MOLECULAR BIOLOGY, 1983, 164 (02) :237-282
[8]   SERUM PROSTATE-SPECIFIC ANTIGEN COMPLEXED TO ALPHA-1-ANTICHYMOTRYPSIN AS AN INDICATOR OF PROSTATE-CANCER [J].
CHRISTENSSON, A ;
BJORK, T ;
NILSSON, O ;
DAHLEN, U ;
MATIKAINEN, MT ;
COCKETT, ATK ;
ABRAHAMSSON, PA ;
LILJA, H .
JOURNAL OF UROLOGY, 1993, 150 (01) :100-105
[9]   ENZYMATIC-ACTIVITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS REACTIONS WITH EXTRACELLULAR SERINE PROTEINASE-INHIBITORS [J].
CHRISTENSSON, A ;
LAURELL, CB ;
LILJA, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 194 (03) :755-763